Dem Senators Object To Commerce Section 232 Tariff Processes

By Margaret Spiegelman, Jessica Karins / October 28, 2025 at 3:00 PM

A group of Democratic senators is demanding greater transparency and “accountability” from Commerce Secretary Howard Lutnick on the administration’s use of a national security statute to impose duties on an expanding number of sectors, including pharmaceuticals and medical devices, charging that those measures have undermined the law’s purpose.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.